Titre :

Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke

Auteur(s) :

Mas, Jean-Louis [Auteur]
Derumeaux, Genevieve [Auteur]
Guillon, Benoit [Auteur]
Massardier, Evelyne [Auteur]
Hosseini, Hassan [Auteur]
Mechtouff, Laura [Auteur]
Arquizan, Caroline [Auteur]
Bejot, Yannick [Auteur]
Vuillier, Fabrice [Auteur]
Detante, Olivier [Auteur]
Guidoux, Celine [Auteur]
Canaple, Sandrine [Auteur]
Vaduva, Claudia [Auteur]
Dequatre-Ponchelle, Nelly [Auteur]
Sibon, Igor [Auteur]
Garnier, Pierre [Auteur]
Ferrier, Anna [Auteur]
Timsit, Serge [Auteur]
Robinet-Borgomano, Emmanuelle [Auteur]
Sablot, Denis [Auteur]
Lacour, Jean-Christophe [Auteur]
Zuber, Mathieu [Auteur]
Favrole, Pascal [Auteur]
Pinel, Jean-François [Auteur]
Apoil, Marion [Auteur]
Reiner, Peggy [Auteur]
Lefebvre, Catherine [Auteur]
Guerin, Patrice [Auteur]
Piot, Christophe [Auteur]
Rossi, Roland [Auteur]
Dubois-Rande, Jean-Luc [Auteur]
Eicher, Jean-Christophe [Auteur]
Meneveau, Nicolas [Auteur]
Lusson, Jean-Rene [Auteur]
Bertrand, Bernard [Auteur]
Schleich, Jean-Marc [Auteur]
Godart, Francois [Auteur]
Thambo, Jean-Benoit [Auteur]
Leborgne, Laurent [Auteur]
Michel, Patrik [Auteur]
Pierard, Luc A. [Auteur]
Turc, Guillaume [Auteur]
Barthelet, Martine [Auteur]
Charles-Nelson, Anais [Auteur]
Weimar, Christian [Auteur]
Moulin, Thierry [Auteur]
Juliard, Jean-Michel [Auteur]
Chatellier, Gilles [Auteur]

Titre de la revue :

The New England journal of medicine

Nom court de la revue :

N. Engl. J. Med.

Numéro :

377

Pagination :

1011-1021

Date de publication :

2017-09-14

ISSN :

0028-4793

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have been inconclusive. We investigated whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke would ...
Lire la suite >Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have been inconclusive. We investigated whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke would benefit from PFO closure or anticoagulation, as compared with antiplatelet therapy. In a multicenter, randomized, open-label trial, we assigned, in a 1:1:1 ratio, patients 16 to 60 years of age who had had a recent stroke attributed to PFO, with an associated atrial septal aneurysm or large interatrial shunt, to transcatheter PFO closure plus long-term antiplatelet therapy (PFO closure group), antiplatelet therapy alone (antiplatelet-only group), or oral anticoagulation (anticoagulation group) (randomization group 1). Patients with contraindications to anticoagulants or to PFO closure were randomly assigned to the alternative noncontraindicated treatment or to antiplatelet therapy (randomization groups 2 and 3). The primary outcome was occurrence of stroke. The comparison of PFO closure plus antiplatelet therapy with antiplatelet therapy alone was performed with combined data from randomization groups 1 and 2, and the comparison of oral anticoagulation with antiplatelet therapy alone was performed with combined data from randomization groups 1 and 3. A total of 663 patients underwent randomization and were followed for a mean (±SD) of 5.3±2.0 years. In the analysis of randomization groups 1 and 2, no stroke occurred among the 238 patients in the PFO closure group, whereas stroke occurred in 14 of the 235 patients in the antiplatelet-only group (hazard ratio, 0.03; 95% confidence interval, 0 to 0.26; P<0.001). Procedural complications from PFO closure occurred in 14 patients (5.9%). The rate of atrial fibrillation was higher in the PFO closure group than in the antiplatelet-only group (4.6% vs. 0.9%, P=0.02). The number of serious adverse events did not differ significantly between the treatment groups (P=0.56). In the analysis of randomization groups 1 and 3, stroke occurred in 3 of 187 patients assigned to oral anticoagulants and in 7 of 174 patients assigned to antiplatelet therapy alone. Among patients who had had a recent cryptogenic stroke attributed to PFO with an associated atrial septal aneurysm or large interatrial shunt, the rate of stroke recurrence was lower among those assigned to PFO closure combined with antiplatelet therapy than among those assigned to antiplatelet therapy alone. PFO closure was associated with an increased risk of atrial fibrillation. (Funded by the French Ministry of Health; CLOSE ClinicalTrials.gov number, NCT00562289 .).Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

CHU Lille
CNRS
Inserm
Université de Lille

Collections :

• Lille Neurosciences & Cognition (LilNCog) - U 1172

Équipe(s) de recherche :

Troubles cognitifs dégénératifs et vasculaires

Date de dépôt :

2019-11-27T14:34:08Z